{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:16:29Z","timestamp":1649088989392},"reference-count":11,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.neurol.2011.08.009","type":"journal-article","created":{"date-parts":[[2011,11,19]],"date-time":"2011-11-19T13:01:15Z","timestamp":1321707675000},"page":"951-954","source":"Crossref","is-referenced-by-count":0,"title":["Les actualit\u00e9s sur les polyneuropathies axonales en 2010"],"prefix":"10.1016","volume":"167","author":[{"given":"S.","family":"Attarian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2011.08.009_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mus.21511","article-title":"Driving with polyneuropathy","volume":"41","author":"Cho","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2011.08.009_bib0010","unstructured":"Coelho TLM, da Silva AM, Cruz MW, Plant\u00e9-Bordeneuve V, Lozeron P, Suhr OB, et al. A comprehensive evaluation of the disease-modifying effects of tafamidis in patients with transthyretin type familial amyloid polyneuropathy. 2010a; AAN: P02.075."},{"key":"10.1016\/j.neurol.2011.08.009_bib0015","unstructured":"Coelho TLM, da Silva AM, Cruz MW, Plant\u00e9-Bordeneuve V, Lozeron P, Suhr OB, et al. Tafamidis (Fx-1006A): a first-in-class disease-modifying therapy for transthyretin type familial amyloid polyneuropathy. 2010b; AAN S08.001."},{"key":"10.1016\/j.neurol.2011.08.009_bib0020","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1212\/WNL.0b013e3181d55f4d","article-title":"Stem cell transplantation in patients with autonomic neuropathy due to primary (AL) amyloidosis","volume":"74","author":"Dingli","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.08.009_bib0025","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs NPhys trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2011.08.009_bib0030","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/mus.21549","article-title":"Electrical stimulation impairs early functional recovery and accentuates skeletal muscle atrophy after sciatic nerve crush injury in rats","volume":"41","author":"Gigo-Benato","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2011.08.009_bib0035","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/mus.21638","article-title":"Polyneuropathy caused by cobalt-chromium metallosis after total hip replacement","volume":"42","author":"Ikeda","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2011.08.009_bib0040","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/S0140-6736(07)60457-7","article-title":"The operation of the century: total hip replacement","volume":"370","author":"Learmonth","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.neurol.2011.08.009_bib0045","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1212\/WNL.0b013e3181d5279e","article-title":"Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial","volume":"74","author":"Pace","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2011.08.009_bib0050","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mus.21561","article-title":"Primary amyloidosis presenting as upper limb multiple mononeuropathies","volume":"41","author":"Tracy","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2011.08.009_bib0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc09-0606","article-title":"Association of metformin, elevated homocysteine and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy","volume":"33","author":"Wile","year":"2010","journal-title":"Diabetes Care"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378711003717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T10:25:35Z","timestamp":1543400735000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378711003717"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":11,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0035378711003717"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2011.08.009","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}